✦ LIBER ✦

A phase II study of sequential carboplatin, paclitaxel and topotecan in patients with previously untreated advanced ovarian cancer

✍ Scribed by Guppy, A E; Nelstrop, A E; Foster, T; Agarwal, R; Seckl, M J; Rustin, G J S

Book ID: 109997953
Publisher: Nature Publishing Group
Year: 2004
Tongue: English
Weight: 99 KB
Volume: 90
Category: Article
ISSN: 0007-0920
DOI: 10.1038/sj.bjc.6601618

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomised phase II study of ASA404 comb

Randomised phase II study of ASA404 combined with carboplatin and paclitaxel in previously untreated advanced non-small cell lung cancer

✍ McKeage, M J; Von Pawel, J; Reck, M; Jameson, M B; Rosenthal, M A; Sullivan, R; 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 174 KB

A phase II clinical trial of topotecan a

A phase II clinical trial of topotecan and carboplatin in patients with newly diagnosed advanced epithelial ovarian cancer

✍ F. VECCHIONE; R. FRUSCIO; T. DELL’ANNA; A. GARBI; R. GARCIA PARRA; S. CORSO; A.A 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB

Weekly administration of topotecan and p

Weekly administration of topotecan and paclitaxel in pretreated advanced cancer patients: a phase I/II study

✍ George P. Stathopoulos; Sotiris K. Rigatos; Christos Christodoulou; Nikos A. Mal 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 182 KB

Phase II study of carboplatin followed b

Phase II study of carboplatin followed by sequential gemcitabine and paclitaxel as first-line treatment for advanced ovarian cancer

✍ M. FRIEDLANDER; M. BUCK; D. WYLD; M. FINDLAY; B. FITZHARRIS; P. DE SOUZA; T. DAV 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

Phase I/II trial of docetaxel and carbop

Phase I/II trial of docetaxel and carboplatin in previously untreated patients with advanced non-small-cell lung cancer

✍ Akira Shoji; Takashi Ogura; Kaneo Suzuki; Hiroshi Takahashi; Kenichi Takahashi; 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 67 KB

Phase II study of daunorubicin in previo

Phase II study of daunorubicin in previously untreated patients with advanced colorectal carcinoma

✍ Harvey, J. ;Bonnem, E. ;Grady, K. ;Goodman, A. ;Schein, P. 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

Fourteen patients with advanced measurable colorectal cancer were treated with daunorubicin hydrochloride (DNR). The drug was administered at a dose of 15 mg/m2 on day 1 through 3 and 8 through 10. After a Cday rest period DNR was given in weekly injections of 15 mg/m2. There were no partial or comp